4//SEC Filing
Kaufman Jonathan H 4
Accession 0001753926-25-000019
CIK 0001347242other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 9:22 PM ET
Size
63.8 KB
Accession
0001753926-25-000019
Insider Transaction Report
Form 4
Kaufman Jonathan H
DirectorSee remarks below.10% Owner
Transactions
- Other
Series C Voting Convertible Preferred Stock
2024-12-31+42,933→ 303,041 total(indirect: By Self as proxy and power of attorney for Spartan and an Affiliate (each as defined below))Exercise: $1.00→ Common Stock (42,933 underlying) - Other
Common Stock Purchase Warrants
2024-12-31+11,795→ 11,795 total(indirect: By Self as proxy and power of attorney for Spartan)Exercise: $1.00From: 2024-12-31Exp: 2029-12-31→ Common Stock (11,795 underlying)
Footnotes (3)
- [F1]Such Series C Voting Convertible Preferred Stock, par value $0.0001 per share ("Preferred Stock"), and the common stock, par value $0.0001 per share, of the issuer ("Common Stock"), issuable upon conversion of Preferred Stock ("Conversion Shares") and exercise of the Common Stock purchase warrants (the "Warrant Shares", and collectively with the Preferred Stock and Conversion Shares, "Securities") are subject to an irrevocable proxy and power of attorney, effective December 20, 2024, between the reporting person and Spartan Capital Securities, LLC ("Spartan"), pursuant to which the reporting person has voting power over all Securities held by Spartan and its Affiliates (defined under Rule 405 of the Securities Act of 1933, as amended) or any person or entity acting as a group therewith ("Proxy and POA"). The reporting person disclaims beneficial ownership of the Securities and such warrants except to the extent of his pecuniary interest therein, if any.
- [F2]Each share of Preferred Stock is convertible into shares of Common Stock on or after the date on which the registration statement filed by the issuer registering the reoffer and resale of the Conversion Shares has been declared effective by the U.S. Securities Exchange Commission.
- [F3]The conversion rights of the Preferred Stock do not expire.
Documents
Issuer
LIPELLA PHARMACEUTICALS INC.
CIK 0001347242
Entity typeother
Related Parties
1- filerCIK 0001959250
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 9:22 PM ET
- Size
- 63.8 KB